Zyla Life Sciences Total Long-Term Debt
Zyla Life Sciences had Total Long-Term Debt of $103.28 million as of 2020-03-31, per its 10-Q filed 2020-05-14.
Discontinued › Balance Sheet › Liabilities
us-gaap:LongTermDebt · last filed 2020-05-14
- 2020-03-31: Long-term Debt $103.28M.
- 2019-12-31: Long-term Debt $103.94M.
- 2019-09-30: Long-term Debt $103.58M.
- 2019-06-30: Long-term Debt $101.63M.
| Period end | Long-term Debt | Long-term Debt as first filed |
|---|---|---|
| 2020-03-31 | $103.28M 10-Q · filed 2020-05-14 | |
| 2019-12-31 | $103.94M 10-Q · filed 2020-05-14 | |
| 2019-09-30 | $103.58M 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $101.63M 10-Q · filed 2019-08-13 | |
| 2019-03-31 | $100.59M 10-Q · filed 2019-05-17 | |
| 2018-06-30 | $3.05M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $2.99M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $2.97M 10-Q · filed 2018-08-09 | $72.43M 10-K · filed 2018-03-16 |
| 2017-03-31 | $2.97M 10-Q · filed 2018-05-10 | |
| 2016-12-31 | $34.81M 10-K · filed 2018-03-16 |